The Oncology Institute, Inc. TOI Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s accounts receivable?
- The Oncology Institute, Inc. (TOI) reported accounts receivable of $58.13M in Q1 2026.
- How has The Oncology Institute, Inc.'s accounts receivable changed year-over-year?
- The Oncology Institute, Inc.'s accounts receivable increased by 17.9% year-over-year, from $49.32M to $58.13M.
- What is the long-term trend for The Oncology Institute, Inc.'s accounts receivable?
- Over 4 years (2021 to 2025), The Oncology Institute, Inc.'s accounts receivable has grown at a 74.3% compound annual growth rate (CAGR), from $24.2M to $223.62M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.